Human Papillomavirus Vaccination Coverage in Children Ages 9–17 Years: United States, 2022
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Human Papillomavirus Vaccination Coverage in Children Ages 9–17 Years: United States, 2022

Filetype[PDF-494.00 KB]


  • English
    • Details Supporting Files You May Also Like

    Details:

    • Personal Author:
    • Corporate Authors:
      National Center for Health Statistics (U.S.)
    • Description:
      Human papillomavirus (HPV) is the most common sexually transmitted infection in men and women in the United States (1). Vaccination prevents and controls HPV infection and associated outcomes, including genital warts, precancerous lesions, and certain cancers, such as cervical, vaginal, vulvar, anal, penile, and oropharyngeal (2,3). HPV vaccination in the United States has been recommended for girls since 2006 and for boys since 2011 and requires multiple doses (2,3). This vaccine, targeted for children ages 11–12 years, may be started at age 9. This report uses parent-reported data from the 2022 National Health Interview Survey to describe the percentage of children ages 9–17 years who received at least one dose of the HPV vaccine by selected sociodemographic and health characteristics.

      Key findings: Data from the National Health Interview Survey

      ● In 2022, 38.6% of children ages 9–17 years had received one or more human papillomavirus (HPV) vaccine doses.

      ● Children with private health insurance (41.5%) were most likely to have received one or more HPV vaccine doses compared with children with Medicaid coverage (37.0%), other government coverage (30.2%), and those without insurance (20.7%).

      ● The percentage of children who have received one or more HPV vaccine doses was higher among those with disability.

      ● Children living in large central metropolitan areas (39.4%), large fringe metropolitan areas (41.1%), and medium and small metropolitan areas (39.4%) were more likely to have received one or more HPV vaccine doses, compared with children living in nonmetropolitan areas (30.0%).

      Suggested citation: Villarroel MA, Galinsky AM, Lu PJ, Pingali C. Human papillomavirus vaccination coverage in children ages 9–17 years: United States, 2022. NCHS Data Brief, no 495. Hyattsville, MD: National Center for Health Statistics. 2024. DOI: https://dx.doi.org/10.15620/cdc:145593.

      CS346807

    • Subjects:
    • Series:
      NCHS data brief ; no. 495
    • Document Type:
      Report
    • Name as Subject:
      National Health Interview Survey (U.S.)
    • Place as Subject:
      United States
    • Collection(s):
    • Main Document Checksum:
    • Download URL:
    • File Type:

    Supporting Files

    More +

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov